Zenas BioPharma, Inc.

NasdaqGS:ZBIO Stock Report

Market Cap: US$501.5m

Zenas BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ZBIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Nov 24BuyUS$148,925Leon MoulderIndividual10,000US$15.00
20 Sep 24BuyUS$360,820Tellus BioVentures, LLCCompany20,000US$18.97
16 Sep 24BuyUS$7,480,000Longitude Capital Management Co., LLCCompany440,000US$17.00
16 Sep 24BuyUS$15,000,001Zebra Aggregator, LPCompany882,353US$17.00
16 Sep 24BuyUS$37,999,998SR One Capital Management, LPCompany2,235,294US$17.00
16 Sep 24BuyUS$5,100,000Fairmount Funds Management LLCCompany300,000US$17.00
16 Sep 24BuyUS$7,480,000Longitude Capital Management Co., LLCCompany440,000US$17.00
13 Sep 24BuyUS$999,991Hongbo LuIndividual58,823US$17.00

Insider Trading Volume

Insider Buying: ZBIO insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZBIO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders261,7360.626%
General Public4,344,97010.4%
Public Companies4,513,16110.8%
VC/PE Firms10,027,42124%
Institutions22,643,74954.2%

Dilution of Shares: ZBIO only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 87.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.8%
SR One Capital Management, LP
4,911,539US$58.9m1,490%10.13%
9%
Zebra Aggregator, LP
3,761,359US$45.1m1,030%no data
7.41%
Xencor, Inc.
3,098,380US$37.2m768%no data
6.25%
New Enterprise Associates, Inc.
2,613,948US$31.4m1,480%1.23%
5.99%
Longitude Capital Management Co., LLC
2,501,934US$30.0m954%4.68%
4.79%
FMR LLC
2,000,000US$24.0m0%no data
4.53%
Fairmount Funds Management LLC
1,892,806US$22.7m932%1.61%
4.4%
NVP Associates, LLC
1,838,482US$22.1m1,010%2.73%
4%
Tellus BioVentures, LLC
1,672,039US$20.1m0%no data
3.74%
Deerfield Management Company, L.P. Series C
1,562,942US$18.8m0%0.27%
3.59%
Wellington Management Group LLP
1,501,428US$18.0m0%no data
3.39%
Bristol-Myers Squibb Company
1,414,781US$17.0m768%no data
2.83%
Vivo Capital, LLC
1,183,260US$14.2m0%1.0%
2.77%
Federated Hermes, Inc.
1,158,000US$13.9m0%0.03%
2.75%
Novo Holdings A/S
1,150,000US$13.8m0%0.01%
2.74%
Perceptive Advisors LLC
1,144,035US$13.7m0%0.26%
2.1%
Rock Springs Capital Management LP
878,667US$10.5m0%0.31%
1.56%
Pivotal BioVenture Partners LLC
650,695US$7.8m0%2.64%
1.16%
T. Rowe Price Group, Inc.
486,854US$5.8m0%no data
0.72%
ArrowMark Colorado Holdings, LLC
300,000US$3.6m0%0.04%
0.46%
Eversept Partners, L.P.
190,531US$2.3m0%0.16%
0.41%
Leon Moulder
171,155US$2.1m6.21%no data
0.36%
The Vanguard Group, Inc.
150,000US$1.8m0%no data
0.36%
Monashee Investment Management, LLC
150,000US$1.8m0%0.17%
0.32%
Goldman Sachs Group, Investment Banking and Securities Investments
132,400US$1.6m0%no data